BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 6804143)

  • 1. Isolation and characterization of circulating immune complexes in cystic fibrosis.
    Moss RB; Hsu YP
    Clin Exp Immunol; 1982 Feb; 47(2):301-8. PubMed ID: 6804143
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating immune complexes, antibodies to Pseudomonas aeruginosa, and pulmonary status in cystic fibrosis.
    Lagacé J; Mercier J; Fréchette M; Fournier D; Dubreuil M; Lamarre A; Lapointe JR; Montplaisir S
    J Clin Lab Immunol; 1989 Sep; 30(1):7-11. PubMed ID: 2534928
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic implications of circulating immune complexes and Pseudomonas aeruginosa-specific antibodies in cystic fibrosis.
    Dasgupta MK; Lam J; Döring G; Harley FL; Zuberbuhler P; Lam K; Reichert A; Costerton JW; Dossetor JB
    J Clin Lab Immunol; 1987 May; 23(1):25-30. PubMed ID: 3112403
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nonopsonic antibodies in cystic fibrosis. Pseudomonas aeruginosa lipopolysaccharide-specific immunoglobulin G antibodies from infected patient sera inhibit neutrophil oxidative responses.
    Eichler I; Joris L; Hsu YP; Van Wye J; Bram R; Moss R
    J Clin Invest; 1989 Dec; 84(6):1794-804. PubMed ID: 2512330
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Anti-Pseudomonas aeruginosa antibodies, circulating immune complexes, and anticytoplasm antibodies of neutrophils in patients with cystic fibrosis with and without Pseudomonas aeruginosa colonization].
    Chiappini E; Taccetti G; Campana S; Turchini S; Marianelli L
    Pediatr Med Chir; 2001; 23(1):27-30. PubMed ID: 11486418
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Significance of circulating immune complexes in pulmonary tuberculosis.
    Samuel AM; Ashtekar MD; Ganatra RD
    Clin Exp Immunol; 1984 Nov; 58(2):317-24. PubMed ID: 6437714
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating immune complexes in cystic fibrosis.
    Berdischewsky M; Pollack M; Young LS; Chia D; Osher AB; Barnett EV
    Pediatr Res; 1980 Jun; 14(6):830-3. PubMed ID: 6773019
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined evaluation of circulating immune complexes and antibodies to Pseudomonas aeruginosa as an immunologic profile in relation to pulmonary function in cystic fibrosis.
    Dasgupta MK; Zuberbuhler P; Abbi A; Harley FL; Brown NE; Lam K; Dossetor JB; Costerton JW
    J Clin Immunol; 1987 Jan; 7(1):51-8. PubMed ID: 3104391
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional importance of cystic fibrosis immunoglobulin G fragments generated by Pseudomonas aeruginosa elastase.
    Bainbridge T; Fick RB
    J Lab Clin Med; 1989 Dec; 114(6):728-33. PubMed ID: 2512365
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibacterial precipitins and autoantibodies in serum of patients with cystic fibrosis.
    Høiby N; Wiik A
    Scand J Respir Dis; 1975 May; 56(1):38-46. PubMed ID: 238280
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The immunoglobulin G subclass composition of immune complexes in cystic fibrosis. Implications for the pathogenesis of the Pseudomonas lung lesion.
    Hornick DB; Fick RB
    J Clin Invest; 1990 Oct; 86(4):1285-92. PubMed ID: 2120286
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune complexes and Pseudomonas aeruginosa antibodies in cystic fibrosis.
    Van Bever HP; Gigase PL; De Clerck LS; Bridts CH; Franckx H; Stevens WJ
    Arch Dis Child; 1988 Oct; 63(10):1222-8. PubMed ID: 3143315
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating immune complexes in patients with usual interstitial pulmonary fibrosis: partial characterization and relationship with Thermoactinomyces vulgaris.
    Cocchiara R; Giallongo A; Amoroso S; Spina G; Stancampiano R; Geraci D
    Immunology; 1981 Dec; 44(4):817-25. PubMed ID: 7319561
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating immune complexes in patients with Candida albicans infections.
    Burges G; Holley HP; Virella G
    Clin Exp Immunol; 1983 Jul; 53(1):165-74. PubMed ID: 6872325
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 125I-Clq-binding and specific antibodies as indicators of pulmonary disease activity in cystic fibrosis.
    Moss RB; Hsu YP; Lewiston NJ
    J Pediatr; 1981 Aug; 99(2):215-22. PubMed ID: 7252678
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nonspecific immunoglobulin synthesis and elevated IgG levels in rabbits immunized with mucoid exopolysaccharide from cystic fibrosis isolates of Pseudomonas aeruginosa.
    Pier GB; Elcock ME
    J Immunol; 1984 Aug; 133(2):734-9. PubMed ID: 6234359
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating immune complexes in pulmonary tuberculosis.
    Ashtekar MD; Samuel AM
    J Clin Lab Immunol; 1985 Oct; 18(2):91-5. PubMed ID: 3935794
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The detection of circulating immune complexes containing C1q and IgG using a new rapid serum ELISA test system.
    Reckel RP; Harris J; Botsko E; Wellerson R; Varga S
    Diagn Immunol; 1984; 2(4):228-37. PubMed ID: 6335421
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating immune complexes in cystic fibrosis and their correlation to clinical parameters.
    Disis ML; McDonald TL; Colombo JL; Kobayashi RH; Angle CR; Murray S
    Pediatr Res; 1986 May; 20(5):385-90. PubMed ID: 3714348
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immune complexes and humoral response to Pseudomonas aeruginosa in cystic fibrosis.
    Moss RB; Lewiston NJ
    Am Rev Respir Dis; 1980 Jan; 121(1):23-9. PubMed ID: 6766286
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.